India to Maldives: Pembrolizumab Export Trade Route

The India to Maldives Pembrolizumab corridor is one of India's established pharmaceutical export routes, with 32 shipments documented worth a combined $161.9K USD. The route is dominated by NU HOSPITALS PRIVATE LIMITED, which alone accounts for roughly 59% of all export value, reflecting the consolidated nature of India's pembrolizumab manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $5.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with pembrolizumab's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 30.2%, placing it at rank #4 among India's top pembrolizumab export destinations globally.

On the import side, key buyers of Indian pembrolizumab in Maldives include INDIRA GANDHI MEMORIAL HOSPITAL, INDIRA GANDHI MEMORIAL HOSPITAL , TREE TOP HEALTH PVT LIMITED and 1 others. INDIRA GANDHI MEMORIAL HOSPITAL is the single largest importer with 23 shipments valued at $95.1K USD.

India's pembrolizumab exports to Maldives are driven primarily by a handful of large-scale manufacturers. NU HOSPITALS PRIVATE LIMITED with 23 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Maldives benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — NU HOSPITALS PRIVATE LIMITED, NU HOSPITALS PRIVATE LIMITED , MEDIINOVA — together account for 93% of total trade value on this route. The average shipment value of $5.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as keytruta 100mg pembrolizumab injection and pembrolizumab - injections - 100mg - key, suggesting that buyers in Maldives tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, INDIRA GANDHI MEMORIAL HOSPITAL is the largest importer with 23 shipments worth $95.1K USD — representing 59% of all pembrolizumab imports from India on this route.